If you could vote on Brexit now which option would you choose?
   

Pharma Gilead, Merck step in to help India's drug manufacturers fight surging COVID-19 outbreak


India is in the midst of one of the world’s grimmest COVID-19 outbreaks so far, but for weeks the country has struggled to meet local demand for life-saving drugs and vaccines. Now, drugmakers reliant on India for their own production needs are stepping in to help. Gilead Sciences on Monday said it would help local manufacturers boost production of its COVID-19 antiviral drug remdesivir, marketed as Veklury. The drug is authorized in India for hospitalized adults and children with severe disease. Seven companies in India already produce the drug, but they're not able to keep up with demand amid the crisis. Gilead plans to donate at least 450,000 vials of remdesivir “to help ease the immediate need for treatment.” Supplies of remdesivir in India have been so tight a thriving black market has cropped up.

FiercePharma - April 27, 2021

View the full story here: https://www.fiercepharma.com/pharma/gilead-merck-plan-production-boosts-for-covid-19-drugs-india-amid-surging-outbreak